Once it was demonstrated that ROS induction by MKIs participates in the killing of cancer cells, we wanted to test if derivatives of GSH and SOD, two of the compounds more frequently recommended as antioxidant dietary supplements, could modify MKI action in hepatoma cell lines. Here, SOD1 is linked to hepatocellular carcinoma.